Summary
Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The German generics market had total revenues of $23.0bn in 2018, representing a compound annual growth rate (CAGR) of 4.9% between 2014 and 2018.
- Market consumption volume increased with a CAGR of 0.8% between 2014 and 2018, to reach 87.5% of total pharma volume.
- Germany has one of the highest generics market shares globally, so with the market close to saturation, growth in market consumption is not expected to grow drastically, but there is still potential for slow growth as more healthcare professionals embrace generics.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Germany
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany generics market with five year forecasts by both value and volume
Reasons to buy
- What was the size of the Germany generics market by value in 2018?
- What will be the size of the Germany generics market in 2023?
- What factors are affecting the strength of competition in the Germany generics market?
- How has the market performed over the last five years?
- How large is Germany’s generics market in relation to its regional counterparts?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. Which players have been most successful in the recent past (1-3 years)?
7.3. What mergers or acquisitions have taken place in the last year?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. Pfizer Inc.
8.4. STADA Arzneimittel AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany generics market value: $ million, 2014-18
Table 2: Germany generics market volume: % of total pharma, 2014-18
Table 3: Germany generics market geography segmentation: $ million, 2018
Table 4: Germany generics market value forecast: $ million, 2018-23
Table 5: Germany generics market volume forecast: % of total pharma, 2018-23
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 16: STADA Arzneimittel AG: key facts
Table 17: STADA Arzneimittel AG: Annual Financial Ratios
Table 18: STADA Arzneimittel AG: Key Employees
Table 19: Germany size of population (million), 2014-18
Table 20: Germany gdp (constant 2005 prices, $ billion), 2014-18
Table 21: Germany gdp (current prices, $ billion), 2014-18
Table 22: Germany inflation, 2014-18
Table 23: Germany consumer price index (absolute), 2014-18
Table 24: Germany exchange rate, 2014-18
List of Figures
Figure 1: Germany generics market value: $ million, 2014-18
Figure 2: Germany generics market volume: % of total pharma, 2014-18
Figure 3: Germany generics market geography segmentation: % share, by value, 2018
Figure 4: Germany generics market value forecast: $ million, 2018-23
Figure 5: Germany generics market volume forecast: % of total pharma, 2018-23
Figure 6: Forces driving competition in the generics market in Germany, 2018
Figure 7: Drivers of buyer power in the generics market in Germany, 2018
Figure 8: Drivers of supplier power in the generics market in Germany, 2018
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Germany, 2018
Figure 10: Factors influencing the threat of substitutes in the generics market in Germany, 2018
Figure 11: Drivers of degree of rivalry in the generics market in Germany, 2018
